0.8446
price down icon5.18%   -0.0461
after-market Handel nachbörslich: .87 0.0254 +3.01%
loading
Schlusskurs vom Vortag:
$0.8907
Offen:
$0.8971
24-Stunden-Volumen:
322.09K
Relative Volume:
1.28
Marktkapitalisierung:
$37.20M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-0.8121
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+1.78%
1M Leistung:
-18.00%
6M Leistung:
-71.47%
1J Leistung:
-87.49%
1-Tages-Spanne:
Value
$0.8121
$0.9105
1-Wochen-Bereich:
Value
$0.8121
$0.9658
52-Wochen-Spanne:
Value
$0.595
$6.89

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name
Firmenname
Werewolf Therapeutics Inc
Name
Telefon
617-952-0555
Name
Adresse
200 TALCOTT AVENUE, WATERTOWN
Name
Mitarbeiter
46
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
HOWL's Discussions on Twitter

Vergleichen Sie HOWL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HOWL
Werewolf Therapeutics Inc
0.8446 37.20M 19.94M -37.37M -33.38M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-03 Eingeleitet JMP Securities Mkt Outperform
2023-08-24 Eingeleitet Wedbush Outperform
2023-06-06 Fortgesetzt Jefferies Buy
2021-09-10 Eingeleitet BofA Securities Buy
2021-05-25 Eingeleitet Evercore ISI Outperform
2021-05-25 Eingeleitet H.C. Wainwright Buy
2021-05-25 Eingeleitet Jefferies Buy
2021-05-25 Eingeleitet SVB Leerink Outperform
Alle ansehen

Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten

pulisher
Apr 25, 2025

Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Friday - Defense World

Apr 25, 2025
pulisher
Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform By Investing.com - Investing.com India

Apr 21, 2025
pulisher
Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform - Investing.com

Apr 21, 2025
pulisher
Apr 17, 2025

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Cancer Drug Developer Werewolf Therapeutics Strengthens Leadership Team Amid Promising Clinical Results - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

Werewolf Therapeutics names Steven Bloom as CBO - The Pharma Letter

Apr 17, 2025
pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics Reveals Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Bank of New York Mellon Corp Grows Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 - Investing.com India

Mar 26, 2025
pulisher
Mar 18, 2025

Werewolf Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

HC Wainwright Issues Pessimistic Outlook for HOWL Earnings - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Wedbush Research Analysts Cut Earnings Estimates for HOWL - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Reaffirms Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Inc. (HOWL) reports earnings - Quartz

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c) - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - Bakersfield.com

Mar 11, 2025
pulisher
Mar 11, 2025

HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Mar 11, 2025
pulisher
Mar 04, 2025

Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

What Will Werewolf Therapeutics Reveal at the Leerink Biopharma Conference Next Month? - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Werewolf Therapeutics, Inc. Announces Board Changes and Committee Appointment - Marketscreener.com

Mar 01, 2025
pulisher
Feb 28, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 - Investing.com

Feb 27, 2025
pulisher
Feb 26, 2025

Werewolf Therapeutics Announces Board Resignation and New Appointment - Defense World

Feb 26, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Oncology Pioneer Transform Werewolf's Cancer-Fighting Platform? - StockTitan

Feb 24, 2025
pulisher
Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025
pulisher
Feb 11, 2025

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 11, 2025
pulisher
Feb 07, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - MarketBeat

Feb 07, 2025
pulisher
Jan 28, 2025

Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World

Jan 28, 2025
pulisher
Jan 24, 2025

Barclays PLC Increases Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jan 24, 2025
pulisher
Jan 19, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 13.2% in December - MarketBeat

Jan 19, 2025

Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Kapitalisierung:     |  Volumen (24h):